The California legislature is seeking to ban five additives frequently found in foods. Red Dye No. 3, titanium dioxide, potassium bromate, brominated vegetable oil, and propylparaben, all currently banned in the European Union.
The FDA has been claiming that the ingredients are safe.
The proposed bill AB 418 would prohibit the manufacture, sale, or distribution of any food product in California containing those ingredients.
Assemblymember Jesse Gabriel, one of the bill’s two sponsors, called the ingredients “dangerous and toxic chemicals.
According to the proposed bill, scientific studies have shown significant public health harms, including increased risk of cancer, behavioral issues in children, harm to the reproductive system, and damage to the immune system.
If enacted, California would be the first US state to ban the use of these ingredients.


Japan’s Nikkei Drops as Markets Await Key U.S. Inflation Data
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand
China’s Services Sector Posts Slowest Growth in Five Months as Demand Softens
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data
European Stocks Rise as Markets Await Key U.S. Inflation Data
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 



